Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene

Genes Chromosomes and Cancer

Volumn 33, Issue 2, 2002, Pages 168-177

  Tabor, Maarten P ^a   Van Houten, Viola M M ^a   Kummer, J Alain ^a   Vosjan, Maria J W D ^a   Vlasblom, Ronald ^a   Snow, Gordon B ^a   Leemans, C René ^a   Braakhuis, Boudewijn J M ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CHROMOSOME 12Q; CHROMOSOME 18Q; CHROMOSOME 8P; CHROMOSOME ARM; FEMALE; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; HEAD AND NECK TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; MICROSATELLITE MARKER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

AGED; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HEART NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; LYMPH NODES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SKIN NEOPLASMS; SPLENIC NEOPLASMS;

MARTES PENNANTI;

EID: 0036141366     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10019     Document Type: Article

References (36)

1. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction
2. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue
3. Genetic progression model for head and neck cancer: Implications for field cancerization
4. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
5. Evidence that loss of chromosome 18q is associated with tumor progression
6. Minimal residual disease in head and neck cancer
7. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma
8. Tumor angiogenesis and p53 mutations: Prognosis in head and neck cancer
9. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients
10. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma
11. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations
12. P53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma
13. Upper aerodigestive tract cancers
14. TP53 genetic alterations in head-and-neck carcinomas from Brazil
15. PCNA, Ki-67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck
16. Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis
17. Location of candidate turnout suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas
18. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck
19. The p53 pathway
20. Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottie larynx
21. Chromosome instability contributes to loss of heterozygosity in mice lacking p53
22. Identification of p53 gene mutations in bladder cancers and urine samples
23. TNM classification of malignant tumors
24. Allelic loss in squamous cell carcinomas of the larynx: Discordance between primary and metastatic tumors
25. Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer
26. Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications
27. Clonal heterogeneity in sporadic melanomas as revealed by loss-of- heterozygosity analysis
28. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma
29. P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases
30. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: Methods, reliability, pitfalls, and solutions
31. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas
32. The origins of multiple squamous cell carcinomas in the aerodigestive tract
33. Head and neck cancer
34. P53 mutations in oropharyngeal carcinomas: A comparison of solitary and multiple primary tumours and lymph node metastases
35. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity